Carmella, SG, Han S, Villalta PW, and Hecht SS (2005). Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers' blood. Cancer Epidemiology, Biomarkers and Prevention. 2005;14(11 Pt 1):2669-2672.

Fatemi SH, Stary JM, Hatsukami DK, and Murphy SE. A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia. Schizophrenia Research. 2005;76(2-3):353-356.

Hatsukami DK, Giovino GA, Eissenberg T, Clark PI, Lawrence D, and Leischow S. Methods to assess potential reduced exposure products. Nicotine & Tobacco Research. 2005;7(6):827-844.

Hatsukami DK, Kotlyar M, Allen S, Jensen J, Li S, Le C, and Murphy S. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest. 2005;128(4):2528-2537.

Hatsukami DK, Rennard S, Jorenby D, Fiore M, Koopmeiners J, de Vos A, Horwith G, and Pentel PR. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers. Clinical Pharmacology and Therapeutics. 2005;78(5):456-467.

Hecht SS, Chen M, Yoder A, Jensen J, Hatsukami D, Le C, and Carmella SG. Longitudinal study of urinary phenanthrene metabolite ratios: effect of smoking on the diol epoxide pathway. Cancer Epidemiology, Biomarkers and Prevention. 2005;14(12): 2969-2974.

Hecht SS, Murphy SE, Carmella SG, Li S, Jensen J, Le C, Joseph AM, and Hatsukami DK. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiology, Biomarkers and Prevention. 2005;14(3):693-698.

Joseph AM, Bliss RL, Zhao F, and Lando H. Predictors of smoking reduction without formal intervention. Nicotine & Tobacco Research. 2005;7(2):277-282.

Joseph AM, Hecht SS, Murphy SE, Carmella SG, Le CT, Zhang Y, Han S, and Hatsukami DK. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiology, Biomarkers and Prevention. 2005;14(12):2963-2968.

Keyler DE, Roiko SA, Benlhabib E, LeSage MG, St Peter JV, Stewart S, Fuller S, Le CT, and Pentel PR. Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships. Drug Metabolism and Disposition. 2005;33(7):1056-1061.

Lemmonds CA, Hecht SS, Jensen JA, Murphy SE, Carmella SG, Zhang Y, and Hatsukami DK. Smokeless tobacco topography and toxin exposure. Nicotine & Tobacco Research. 2005;7(3):469-474.

Mooney M, Babb D, Jensen J, and Hatsukami D. Interventions to increase use of nicotine gum: a randomized, controlled, single-blind trial. Nicotine & Tobacco Research. 2005;7(4):565-579.

Tulunay OE, Hecht SS, Carmella SG, Zhang Y, Lemmonds C, Murphy S, and Hatsukami DK. Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers. Cancer Epidemiology, Biomarkers and Prevention. 2005;14(5):1283-1286.